Literature DB >> 19400746

An outbreak of postoperative gram-negative bacterial endophthalmitis associated with contaminated trypan blue ophthalmic solution.

Rebecca Sunenshine1, Maureen Schultz, Mary G Lawrence, Soo Shin, Bette Jensen, Sabiha Zubairi, Ann M Labriola, Alicia Shams, Judith Noble-Wang, Matthew J Arduino, Fred Gordin, Arjun Srinivasan.   

Abstract

We report 6 cases of postsurgical endophthalmitis due to gram-negative bacteria associated with contaminated trypan blue dye from a compounding pharmacy. Unopened trypan blue syringes yielded Pseudomonas aeruginosa and Burkholderia cepacia complex on culture, with pulsed-field gel electrophoresis patterns indistinguishable from patient isolates. Contamination of compounded medications should be considered when investigating outbreaks of postoperative endophthalmitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19400746     DOI: 10.1086/598938

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Insights into β-lactamases from Burkholderia species, two phylogenetically related yet distinct resistance determinants.

Authors:  Krisztina M Papp-Wallace; Magdalena A Taracila; Julian A Gatta; Nozomi Ohuchi; Robert A Bonomo; Michiyoshi Nukaga
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

Review 2.  U.S. Compounding Pharmacy-Related Outbreaks, 2001-2013: Public Health and Patient Safety Lessons Learned.

Authors:  Nadine Shehab; Megan N Brown; Alexander J Kallen; Joseph F Perz
Journal:  J Patient Saf       Date:  2018-09       Impact factor: 2.844

3.  Management strategies to reduce risk of postoperative infections.

Authors:  Anat Galor; Raquel Goldhardt; Sarah R Wellik; Ninel Z Gregori; Harry W Flynn
Journal:  Curr Ophthalmol Rep       Date:  2013-12

Review 4.  Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.

Authors:  Catherine Staes; Jason Jacobs; Jeanmarie Mayer; Jill Allen
Journal:  Am J Health Syst Pharm       Date:  2013-08-01       Impact factor: 2.637

5.  Outbreak of Serratia marcescens bloodstream infections in patients receiving parenteral nutrition prepared by a compounding pharmacy.

Authors:  Neil Gupta; Susan N Hocevar; Heather A Moulton-Meissner; Kelly M Stevens; Mary G McIntyre; Bette Jensen; David T Kuhar; Judith A Noble-Wang; Rick G Schnatz; Shawn C Becker; Eric S Kastango; Nadine Shehab; Alexander J Kallen
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

6.  Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection.

Authors:  John L Chollet; Michael J Jozwiakowski
Journal:  Drug Dev Ind Pharm       Date:  2012-02-13       Impact factor: 3.225

7.  Clinical course, treatment and visual outcome of an outbreak of Burkholderia contaminans endophthalmitis following cataract surgery.

Authors:  Caroline Lind; Karina Olsen; Nina K Angelsen; Einar A Krefting; Kristian Fossen; Kirsten Gravningen; Eliza Depoorter; Peter Vandamme; Geir Bertelsen
Journal:  J Ophthalmic Inflamm Infect       Date:  2021-04-19

Review 8.  Potential risks of pharmacy compounding.

Authors:  Jennifer Gudeman; Michael Jozwiakowski; John Chollet; Michael Randell
Journal:  Drugs R D       Date:  2013-03

Review 9.  Outbreak of Multidrug-resistant Pseudomonas Aeruginosa Endophthalmitis Due to Contaminated Trypan Blue Solution.

Authors:  Pritam Bawankar; Harsha Bhattacharjee; Manabjyoti Barman; Ronel Soibam; Hemalata Deka; Ganesh Chandra Kuri; Jnanankar Medhi
Journal:  J Ophthalmic Vis Res       Date:  2019-07-18

Review 10.  Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors.

Authors:  C James Watson; James D Whitledge; Alicia M Siani; Michele M Burns
Journal:  J Med Toxicol       Date:  2020-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.